The current epidemic of corona virus disease (COVID-19) has resulted in an immense
health burden that became the third leading cause of death and potentially contributed to a …

Following the rapidly increasing number of multisystem inflammatory syndromes in children
(MIS‐C), a similar clinical scenario has been observed in adult patients. Although its …

Background: A proportion of patients' ailments may last after recovering from acute COVID-
19, with episodic and systemic symptoms of unclear etiology potentially involving different …

The effect of nirmatrelvir plus ritonavir (NMV‐r) on post‐acute COVID‐19 sequelae beyond 3
months of SARS‐CoV‐2 infection remains unknown. This retrospective cohort study utilized …

The long‐term risk of herpes zoster (HZ) after recovery from a SARS‐CoV‐2 infection is
unclear. This retrospective cohort study assessed the risk of HZ in patients following a …

Myalgic encephalomyelitis/chronic fatigue (ME/CFS) is a post-infectious, chronic disease
that can lead to severe impairment and, even, total disability. Although the disease has been …

Although a novel oral antiviral agent can improve short‐term COVID‐19 outcomes, its effects
on the long‐term outcomes, namely the risk of major adverse cardiovascular events …

Background and purpose The coronavirus disease 2019 (COVID-19) has been associated
with olfactory dysfunction. The persistent symptoms of anosmia or hyposmia were …

Objectives This retrospective cohort study assessed the clinical effectiveness of
nirmatrelvirplus ritonavir (NMV-r) in treating COVID-19 in patients with liver cirrhosis (LC) …

Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in
large-and medium-sized arteries and is morphologically characterized by asymmetric focal …